Cantel

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Third Quarter Ended April 30, 2020

Retrieved on: 
Thursday, May 21, 2020

LITTLE FALLS, N.J., May 21, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its third quarter ended April 30, 2020 on Thursday, June 4, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.

Key Points: 
  • LITTLE FALLS, N.J., May 21, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its third quarter ended April 30, 2020 on Thursday, June 4, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.
  • To participate in the conference call, dial 1-844-369-8770 (US & Canada) or 1-862-298-0840 (International) approximately 5 to 10 minutes before the beginning of the call.
  • A replay of the presentation will be archived on the Cantel website for those unable to listen live.
  • In addition, the Company will provide a supplemental presentation to complement the conference call.

Cantel Announces Initiatives to Help Fight COVID-19

Retrieved on: 
Wednesday, April 1, 2020

Cantel is working across divisions to bring critical products it manufactures and sells to various end markets to best serve healthcare providers on the front lines.

Key Points: 
  • Cantel is working across divisions to bring critical products it manufactures and sells to various end markets to best serve healthcare providers on the front lines.
  • Cantel is also focused on innovating products that play a major role on the front lines of combatting COVID-19.
  • Cantel is actively working with its medical division to offer this powerful disinfectant to hospital customers to help in the fight against infections.
  • Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.

Cantel Appoints Seth Yellin to Chief Growth Officer

Retrieved on: 
Thursday, February 27, 2020

LITTLE FALLS, N.J., Feb. 27, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE: CMD) announced today that in line with its focus on key growth opportunities, Seth Yellin has been promoted to the newly created role of Executive Vice President and Chief Growth Officer.

Key Points: 
  • LITTLE FALLS, N.J., Feb. 27, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE: CMD) announced today that in line with its focus on key growth opportunities, Seth Yellin has been promoted to the newly created role of Executive Vice President and Chief Growth Officer.
  • Mr. Yellin will continue to be based in Little Falls, NJ and serve on the Executive Leadership Team.
  • Mr. Yellin's primary responsibilities in this expanded role will be identifying and supporting both organic and inorganic initiatives to drive the Company's growth objectives.
  • Prior to joining Cantel, Mr. Yellin worked as a healthcare investment professional most recently at Citadel Global Equities and as an M&A investment banker at UBS.

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2020

Retrieved on: 
Friday, February 21, 2020

LITTLE FALLS,N.J., Feb. 21, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its second quarter ended January 31, 2020 on Thursday, March 5, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.

Key Points: 
  • LITTLE FALLS,N.J., Feb. 21, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its second quarter ended January 31, 2020 on Thursday, March 5, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.
  • To participate in the conference call, dial 1-844-369-8770 (US & Canada) or 1-862-298-0840 (International) approximately 5 to 10 minutes before the beginning of the call.
  • A replay of the presentation will be archived on the Cantel website for those unable to listen live.
  • In addition, the Company will provide a supplemental presentation to complement the conference call.

Hu-Friedy Introduces HuFriedyGroup as the Dental Division of Cantel

Retrieved on: 
Thursday, February 20, 2020

CHICAGO, Feb. 20, 2020 /PRNewswire/ --Hu-Friedy, the world leader in dental instrument manufacturing and instrument reprocessing workflows, today introduced HuFriedyGroup as the Dental Division of Cantel.

Key Points: 
  • CHICAGO, Feb. 20, 2020 /PRNewswire/ --Hu-Friedy, the world leader in dental instrument manufacturing and instrument reprocessing workflows, today introduced HuFriedyGroup as the Dental Division of Cantel.
  • As the Dental Division of Cantel, HuFriedyGroup represents the union of brands, products, services, and solutions under one roof, including Crosstex, Accutron, SPSmedical, Palmero Healthcare, J & J Instruments, and Hu-Friedy.
  • "When we agreed to be acquired by Cantel, we knew it would be important that the identity of our dental division reflect the larger value that we are able to bring to the industry," said Ron Saslow, Chairman, HuFriedyGroup.
  • HuFriedyGroup, the dental division of Cantel, is the global leader in infection prevention, instrument manufacturing, and instrument reprocessing workflows, with over 177 years of collective experience in the dental industry.

Global Sterilization Services Market Outlook 2019-2024: Ethylene Oxide (ETO) Sterilization, Gamma Sterilization, Steam Sterilization, Electron Beam Radiation Sterilization, and Gamma Sterilization - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 4, 2019

The "Sterilization Services Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Sterilization Services Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
  • With the high usage of complex equipment across medical and food processing facilities, the sterilization services are an important practice for a healthy ecosystem.
  • In healthcare facilities, hospital-acquired infections also play a crucial role to include the sterilization methods on a regular basis.
  • Some of the major players in the market are Johnson & Johnson, Steris Corporation, Stryker Corporation, Medistri, and Cantel Medical, among others.

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2019

Retrieved on: 
Monday, November 25, 2019

LITTLE FALLS, N.J., Nov. 25, 2019 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its first quarter ended October 31, 2019 on Tuesday, December 10, 2019 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.

Key Points: 
  • LITTLE FALLS, N.J., Nov. 25, 2019 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its first quarter ended October 31, 2019 on Tuesday, December 10, 2019 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.
  • To participate in the conference call, dial 1-844-602-0380 (US & Canada) or 1-862-298-0970 (International) approximately 5 to 10 minutes before the beginning of the call.
  • A replay of the presentation will be archived on the Cantel website for those unable to listen live.
  • In addition, the Company will provide a supplemental presentation to complement the conference call.

Europe Laboratory Filtration Market Outlook 2019-2027: Analysis on Microfiltration, Nanofiltration, Vacuum Filtration, Ultrafiltration, Reverse Osmosis Technology, and Other Technologies - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 12, 2019

The "Europe Laboratory Filtration Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Laboratory Filtration Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.
  • The European laboratory filtration market is set to grow in terms of revenue, with a CAGR of 5.53% in the forecast years between 2019 and 2027.
  • Germany, the UK, France, Italy, Russia, Spain and countries in rest of Europe together comprise the market for laboratory filtration in the European region.
  • GE Healthcare, Macherey-Nagel, Sigma-Aldrich Corporation, Cantel Medical Corporation and Pall Corporation are the distinguished names in the laboratory filtration market.

Global Laboratory Filtration Market 2019: Top Players are Cantel Medical, Sigma-Aldrich, 3M, GE Healthcare, Pall, Merck Millipore, Sartorius, Thermo Fisher Scientific And Macherey-Nagel

Retrieved on: 
Tuesday, November 5, 2019

DUBLIN, Nov. 5, 2019 /PRNewswire/ -- The "Global Laboratory Filtration Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 5, 2019 /PRNewswire/ -- The "Global Laboratory Filtration Market 2019-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global laboratory filtration market is expected to display an upward trend, with a CAGR of 6.12% in terms of revenue in the forecasting years of 2019 to 2027.
  • The top companies that have been studied in the laboratory filtration market are Cantel Medical Corporation, Sigma-Aldrich Corporation, 3M Company, GE Healthcare, Pall Corporation, Merck Millipore, Sartorius Group, Thermo Fisher Scientific and MACHEREY-NAGEL.
  • GE Healthcare, a subsidiary of GE Company, was founded after the acquisition of Amersham Plc by GE Medical Systems.

Cantel Appoints Karen Prange to Board of Directors

Retrieved on: 
Monday, October 28, 2019

LITTLE FALLS, N.J., Oct. 28, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD), announced today the appointment of Karen Prange to the Company's Board of Directors, bringing to the Board more than 25 years of healthcare and life sciences leadership experience.

Key Points: 
  • LITTLE FALLS, N.J., Oct. 28, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD), announced today the appointment of Karen Prange to the Company's Board of Directors, bringing to the Board more than 25 years of healthcare and life sciences leadership experience.
  • She was also recently appointed to serve on the strategic advisory board of Nuvo Group, an emerging leader in maternal-fetal connected health.
  • "I am pleased to announce Karen's election to the Cantel Board of Directors.
  • Earlier this year, Cantel was recognized by 2020 Women on Boards for gender diversity on its Board of Directors.